Consensus West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Market Closed - Nyse Other stock markets 04:00:01 2024-05-17 pm EDT			5-day change	1st Jan Change
355.6 ^USD	+0.43%		-2.35%	+1.00%

May. 14	Transcript : West Pharmaceutical Services, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
May. 09	West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing	MT

Evolution of the average Target Price on West Pharmaceutical Services, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d1bc1142.J2GHHa9w872CzFkJ5GVKkSKCD4XylYGhPtzrCYwFpx0.dAX3TuwzgMTJ4T8kjxwly0zATsCX3rT5TqiFX79CyHxEN8JfnB212eOLPg~184b96accc3afbda6c0f6a2ecfd68ea7

Analyst Recommendations on West Pharmaceutical Services, Inc.

West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing	May. 09	MT
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating	Apr. 26	MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423	Apr. 26	MT
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400	Apr. 25	MT
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating	Feb. 16	MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating	Feb. 16	MT
Forget about rate cuts...	Feb. 16
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	Feb. 16
Wall Street ends higher as retail sales slump feeds hopes for rate cuts	Feb. 15	RE
KeyBanc Adjusts West Pharmaceutical Services Price Target to $470 From $440, Maintains Overweight Rating	Feb. 13	MT
Jefferies Upgrades West Pharmaceutical Services to Buy From Hold, Adjusts Price Target to $536 From $323	Feb. 07	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
Joe Biden and Xi Jinping almost made up	Nov. 16
ANALYST RECOMMENDATIONS : Abbvie, Burberry, Chevron, Cisco, M&S...	Nov. 16
Stephens Lowers Price Target on West Pharmaceutical Services to $390 From $420, Maintains Overweight Rating	23-10-27	MT
Deutsche Bank Cuts West Pharmaceutical Services Price Target to $350 From $360, Maintains Hold Rating	23-10-27	MT
Keybanc Adjusts Price Target on West Pharmaceutical Services to $440 From $415, Maintains Overweight Rating	23-08-30	MT
KeyBanc Adjusts West Pharmaceutical Services' Price Target to $415 From $385, Keeps Overweight Rating	23-08-21	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $360 From $290, Maintains Hold Rating	23-07-20	MT
Stephens Adjusts West Pharmaceutical Services' Price Target to $420 From $400, Keeps Overweight Rating	23-07-17	MT
UBS Adjusts Price Target on West Pharmaceutical Services to $400 From $365, Maintains Neutral Rating	23-07-10	MT
BofA Securities Upgrades West Pharmaceutical Services to Buy From Neutral, Raises Price Target to $405 From $390	23-06-16	MT
UBS Adjusts West Pharmaceutical Services Price Target to $365 From $356, Maintains Neutral Rating	23-04-28	MT
Stephens Upgrades West Pharmaceutical Services to Overweight From Equalweight, Raises Price Target to $400 From $330	23-04-11	MT